Published • loading... • Updated
Bausch Health Announces 2026 Annual Meeting of Shareholder Results
Shareholders also approved executive pay and renewed PricewaterhouseCoopers LLP as auditor through the 2027 annual meeting, the company said.
- On Tuesday, Bausch Health Companies Inc. held its 2026 Annual Meeting of Shareholders, where shareholders elected all 10 director nominees, including Eiry W. Roberts, M.D., as a new director.
- Shareholders also approved PricewaterhouseCoopers LLP as the Company's auditor until the 2027 Annual Meeting and authorized the board to fix the auditor's remuneration on a non-binding advisory vote.
- Roberts, formerly Chief Medical Officer of Neurocrine Biosciences, Inc., will chair the Science and Technology Committee and brings expertise in clinical development and medical strategy.
- Final voting tallies showed Roberts received 196,972,752 votes, while Amy B. Wechsler, M.D. received 195,813,955 votes, reflecting strong shareholder support for the elected directors.
- The final vote tabulation will be reported to the U.S. Securities and Exchange Commission on Form 8-K and made available on Bausch Health's SEDAR+ profile and website.
Insights by Ground AI
14 Articles
14 Articles
Bennington Banner+13 Reposted by 13 other sources
Bausch Health Announces 2026 Annual Meeting of Shareholder Results
LAVAL, QC, May 19, 2026 /PRNewswire/ -- Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) today announced that shareholders elected all 10 director nominees at its 2026 Annual Meeting of Shareholders ("Annual Meeting") held on May 19, 2026, including Eiry W. Roberts, M.D.,…
Coverage Details
Total News Sources14
Leaning Left4Leaning Right1Center4Last UpdatedBias Distribution45% Left, 44% Center
Bias Distribution
- 45% of the sources lean Left, 44% of the sources are Center
45% Left
L 45%
C 44%
11%
Factuality
To view factuality data please Upgrade to Premium
